Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Drug Resistance

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 72 articles: HTML format

Single Articles

October 2025
1. MIZUSHIMA H, Komori M, Yoshida CA, Miyairi I, et al
   Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae.
   Emerg Infect Dis. 2025;31:2043-2045.
   PubMed     Abstract available
   
   
   
2. CARTEE JC, Cherdtrakulkiat T, Joseph SJ, Kittiyaowamarn R, et al
   Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis-Associated Urethritis Cluster, Thailand.
   Emerg Infect Dis. 2025;31:1992-1997.
   PubMed     Abstract available
   
   
   
3. PERRY J, Rakler T, Arnold K, Wiseman A, et al
   Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020-2023.
   Emerg Infect Dis. 2025;31:1969-1979.
   PubMed     Abstract available
   
   
   
4. RABAULT C, Shuping L, Mpembe R, Quan V, et al
   Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012-2017.
   Emerg Infect Dis. 2025;31:1901-1911.
   PubMed     Abstract available
   
   
   September 2025
5. DO PRADO CM, Spruijtenburg B, Razzolini E, Chiyo L, et al
   Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil.
   Emerg Infect Dis. 2025;31:1783-1792.
   PubMed     Abstract available
   
   
   August 2025
6. LAN S, Liu S, Cui W, Li Z, et al
   Emergence of Novel Fluoroquinolone Resistance Mutations in Mycoplasma bovis, China, 2008-2023.
   Emerg Infect Dis. 2025;31:1676-1679.
   PubMed     Abstract available
   
   
   July 2025
7. HOODA Y, Tanmoy AM, Nath SD, Jui AB, et al
   Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024.
   Emerg Infect Dis. 2025;31:1460-1465.
   PubMed     Abstract available
   
   
   
8. LEFEBVRE B, Martin I, Thorington R, Gitelman J, et al
   Extensively Drug-Resistant Neisseria gonorrhoeae Strain, Canada.
   Emerg Infect Dis. 2025;31:1446-1449.
   PubMed     Abstract available
   
   
   
9. CHARLES H, Greig DR, Swift C, Olonade I, et al
   Epidemiologic and Genomic Investigation of Sexually Transmitted Shigella sonnei, England.
   Emerg Infect Dis. 2025;31:1394-1405.
   PubMed     Abstract available
   
   
   
10. DELMA FZ, Spruijtenburg B, Meis JF, de Jong AW, et al
    Emergence of Flucytosine-Resistant Candida tropicalis Clade, the Netherlands.
    Emerg Infect Dis. 2025;31:1354-1364.
    PubMed     Abstract available
    
    
    June 2025
11. DU T, Silva A, Choi KB, Lybeck C, et al
    Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015-2022.
    Emerg Infect Dis. 2025;31:1109-1120.
    PubMed     Abstract available
    
    
    May 2025
12. DE ALMEIDA JN JR, Dos Santos AR, Trindade MRS, Gold JAW, et al
    Trichophyton indotineae Infection, Sao Paulo, Brazil, 2024.
    Emerg Infect Dis. 2025;31:1049-1051.
    PubMed     Abstract available
    
    
    
13. LI L, Wang X, Xiao Y, Fan B, et al
    Rapid Transmission and Divergence of Vancomycin-Resistant Enterococcus faecium Sequence Type 80, China.
    Emerg Infect Dis. 2025;31:1000-1005.
    PubMed     Abstract available
    
    
    
14. ABOU-CHAKRA N, Astvad KMT, Martinussen J, Munksgaard ASE, et al
    Exponential Clonal Expansion of 5-Fluorocytosine-Resistant Candida tropicalis and New Insights into Underlying Molecular Mechanisms.
    Emerg Infect Dis. 2025;31:977-985.
    PubMed     Abstract available
    
    
    
15. TAKASHITA E, Morita H, Nagata S, Fujisaki S, et al
    Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024.
    Emerg Infect Dis. 2025;31:1019-1023.
    PubMed     Abstract available
    
    
    
16. LLOYD T, Khan SM, Heaton D, Shemsu M, et al
    Genomic Modeling of an Outbreak of Multidrug-Resistant Shigella sonnei, California, USA, 2023-2024.
    Emerg Infect Dis. 2025;31:98-102.
    PubMed     Abstract available
    
    
    
17. MIERNYK KM, Chochua S, Metcalf B, Reasonover A, et al
    Successful Transition to Whole-Genome Sequencing and Bioinformatics to Identify Invasive Streptococcus spp. Drug Resistance, Alaska, USA.
    Emerg Infect Dis. 2025;31:103-108.
    PubMed     Abstract available
    
    
    
18. TORRES LM, Johnson J, Valentine A, Brezak A, et al
    Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA.
    Emerg Infect Dis. 2025;31:25-34.
    PubMed     Abstract available
    
    
    April 2025
19. SAVIN C, Oropeza G, Barboza Fallas LA, Rivas-Solano O, et al
    Genomic Characterization of Yersinia enterocolitica Isolates, Costa Rica.
    Emerg Infect Dis. 2025;31:848-860.
    PubMed     Abstract available
    
    
    
20. PEREYRE S, Laurier-Nadalie C, Balcon C, Henin N, et al
    Spread of Dual-Resistant Mycoplasma genitalium Clone among Men, France, 2021-2022.
    Emerg Infect Dis. 2025;31:854-858.
    PubMed     Abstract available
    
    
    
21. PASCUA PNQ, Chesnokov A, Nguyen HT, Di H, et al
    Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023-2024.
    Emerg Infect Dis. 2025;31:751-760.
    PubMed     Abstract available
    
    
    March 2025
22. JIANG J, Long T, Porter AR, Lovey A, et al
    Carbapenem-Resistant, Virulence Plasmid-Harboring Klebsiella pneumoniae, United States.
    Emerg Infect Dis. 2025;31.
    PubMed     Abstract available
    
    
    
23. PAUL R, Lorenzo F, Lopez B, Alegre MG, et al
    Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006-2022.
    Emerg Infect Dis. 2025;31:601-606.
    PubMed     Abstract available
    
    
    
24. GERUSSI V, Petersen T, Bonnet I, Aubry A, et al
    Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.
    Emerg Infect Dis. 2025;31:633-636.
    PubMed     Abstract available
    
    
    
25. FRANCISCO NM, Gaviraghi A, Alladio F, Huits R, et al
    Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola.
    Emerg Infect Dis. 2025;31:627-629.
    PubMed     Abstract available
    
    
    
26. KONSTANTYNOVSKA O, Synenko T, Honcharenko A, Volobuieva O, et al
    Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
    Emerg Infect Dis. 2025;31:615-617.
    PubMed     Abstract available
    
    
    
27. SHAO Y, Chen M, Cai J, Doi Y, et al
    Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant Meningitis.
    Emerg Infect Dis. 2025;31:591-595.
    PubMed     Abstract available
    
    
    
28. LEBER AL, Embry T, Everhart K, Taveras J, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.
    Emerg Infect Dis. 2025;31:555-558.
    PubMed     Abstract available
    
    
    
29. ZIMENKOV D, Ushtanit A, Gordeeva E, Guselnikova E, et al
    High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia.
    Emerg Infect Dis. 2025;31:525-536.
    PubMed     Abstract available
    
    
    
30. DU PLESSIS M, Mikhari R, de Gouveia L, Duma N, et al
    Corynebacterium diphtheriae Infections, South Africa, 2015-2023.
    Emerg Infect Dis. 2025;31:417-426.
    PubMed     Abstract available
    
    
    January 2025
31. ABDOLRASOULI A, Barton RC, Borman AM
    Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017-2024.
    Emerg Infect Dis. 2025;31:192-194.
    PubMed     Abstract available
    
    
    
32. MACFARQUHAR JK, Bajpai A, Fisher T, Barr C, et al
    Identification and Characterization of Vancomycin-Resistant Staphylococcus aureus CC45/USA600, North Carolina, USA, 2021.
    Emerg Infect Dis. 2025;31:194-196.
    PubMed     Abstract available
    
    
    
33. BRODIKOVA K, Destanque T, Haenni M, Karpiskova R, et al
    Clonal Complex 398 Methicillin-Resistant Staphylococcus aureus Producing Panton-Valentine Leukocidin, Czech Republic, 2023.
    Emerg Infect Dis. 2025;31:174-177.
    PubMed     Abstract available
    
    
    
34. POLANI R, De Francesco A, Tomolillo D, Artuso I, et al
    Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae.
    Emerg Infect Dis. 2025;31:123-124.
    PubMed     Abstract available
    
    
    
35. STROBEL AG, Sahukhan A, Ratu A, Kailawadoko J, et al
    Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji.
    Emerg Infect Dis. 2025;31:32-40.
    PubMed     Abstract available
    
    
    December 2024
36. PRICE ER, McDermott D, Sherman A, Kelley L, et al
    Canine Multidrug-Resistant Pseudomonas aeruginosa Cases Linked to Human Artificial Tears-Related Outbreak.
    Emerg Infect Dis. 2024;30:2689-2691.
    PubMed     Abstract available
    
    
    
37. JIRAWATTANADON P, Bunyaratavej S, Leeyaphan C, Chongtrakool P, et al
    Clinical Manifestations, Antifungal Drug Susceptibility, and Treatment Outcomes for Emerging Zoonotic Cutaneous Sporotrichosis, Thailand.
    Emerg Infect Dis. 2024;30:2583-2592.
    PubMed     Abstract available
    
    
    November 2024
38. TSENG KY, Chen YZ, Zhou ZL, Tsai JN, et al
    Detection in Orchards of Predominant Azole-Resistant Candida tropicalis Genotype Causing Human Candidemia, Taiwan.
    Emerg Infect Dis. 2024;30:2323-2332.
    PubMed     Abstract available
    
    
    
39. GHOSH M, Iarikov D, Qi XK, Rubin D, et al
    Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs.
    Emerg Infect Dis. 2024;30:2227-2230.
    PubMed     Abstract available
    
    
    
40. GAO R, Pascua PNQ, Chesnokov A, Nguyen HT, et al
    Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States.
    Emerg Infect Dis. 2024;30:2303-2312.
    PubMed     Abstract available
    
    
    October 2024
41. FRENCH NP, Thomas KM, Amani NB, Benschop J, et al
    Population Structure and Antimicrobial Resistance in Campylobacter jejuni and C. coli Isolated from Humans with Diarrhea and from Poultry, East Africa.
    Emerg Infect Dis. 2024;30:2079-2089.
    PubMed     Abstract available
    
    
    
42. ODUNDO EA, Kipkirui EC, Koech MC, Kirui MC, et al
    Azithromycin Resistance Patterns in Escherichia coli and Shigella before and after COVID-19, Kenya.
    Emerg Infect Dis. 2024;30:86-93.
    PubMed     Abstract available
    
    
    
43. LE VAN A, Rahman N, Sandy R, Dozier N, et al
    Common Patterns and Unique Threats in Antimicrobial Resistance as Demonstrated by Global Gonococcal Surveillance.
    Emerg Infect Dis. 2024;30:62-70.
    PubMed     Abstract available
    
    
    
44. ANDERSON C, Lebreton F, Mills E, Jones B, et al
    Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021.
    Emerg Infect Dis. 2024;30:47-52.
    PubMed     Abstract available
    
    
    
45. BYARUGABA DK, Osman TS, Sayyouh OM, Wokorach G, et al
    Genomic Epidemiology of Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan.
    Emerg Infect Dis. 2024;30:33-40.
    PubMed     Abstract available
    
    
    September 2024
46. GOLD JAW, Benedict K, Lockhart SR, Lutfy C, et al
    Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States.
    Emerg Infect Dis. 2024;30:1978-1980.
    PubMed     Abstract available
    
    
    
47. CAMELENA F, Merimeche M, Brousseau J, Mainardis M, et al
    Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.
    Emerg Infect Dis. 2024;30:1903-1906.
    PubMed     Abstract available
    
    
    August 2024
48. WU TH, Fang YP, Liu FC, Pan HH, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017-2023.
    Emerg Infect Dis. 2024;30:1692-1696.
    PubMed     Abstract available
    
    
    
49. XIU L, Zhang L, Peng J
    Surge in Ceftriaxone-Resistant Neisseria gonorrhoeae FC428-Like Strains, Asia-Pacific Region, 2015-2022.
    Emerg Infect Dis. 2024;30:1683-1686.
    PubMed     Abstract available
    
    
    
50. BAUM M, Anuka E, Davidovich-Cohen M, Rokney A, et al
    ST913-IVa-t991 Methicillin-Resistant Staphylococcus aureus among Pediatric Patients, Israel.
    Emerg Infect Dis. 2024;30:1714-1718.
    PubMed     Abstract available
    
    
    
51. MCQUAID CF, Ryckman TS, Menzies NA, White RG, et al
    Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
    Emerg Infect Dis. 2024;30:1571-1579.
    PubMed     Abstract available
    
    
    
52. ARENDRUP MC, Hare RK, Jorgensen KM, Bollmann UE, et al
    Environmental Hot Spots and Resistance-Associated Application Practices for Azole-Resistant Aspergillus fumigatus, Denmark, 2020-2023.
    Emerg Infect Dis. 2024;30:1531-1541.
    PubMed     Abstract available
    
    
    July 2024
53. OUK V, Say HL, Virak M, Deng S, et al
    World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023.
    Emerg Infect Dis. 2024;30:1493-1495.
    PubMed     Abstract available
    
    
    
54. PATEL MC, Nguyen HT, Pascua PNQ, Gao R, et al
    Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.
    Emerg Infect Dis. 2024;30:1410-1415.
    PubMed     Abstract available
    
    
    June 2024
55. YANG Y, Xu S, He H, Zhu X, et al
    Yersinia ruckeri Infection and Enteric Redmouth Disease among Endangered Chinese Sturgeons, China, 2022.
    Emerg Infect Dis. 2024;30:1125-1132.
    PubMed     Abstract available
    
    
    
56. MANGALEA MR, Halpin AL, Haile M, Elkins CA, et al
    Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated Infections.
    Emerg Infect Dis. 2024;30:1069-1076.
    PubMed     Abstract available
    
    
    
57. GROME HN, Grass JE, Duffy N, Bulens SN, et al
    Carbapenem-Resistant and Extended-Spectrum beta-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.
    Emerg Infect Dis. 2024;30:1104-1114.
    PubMed    
    
    
    May 2024
58. DHABAAN G, Jamal H, Ouellette D, Alexander S, et al
    Detection of OXA-181 Carbapenemase in Shigella flexneri.
    Emerg Infect Dis. 2024;30:1048-1050.
    PubMed     Abstract available
    
    
    
59. ABBARA S, Guillemot D, Smith DRM, El Oualydy S, et al
    Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.
    Emerg Infect Dis. 2024;30:974-983.
    PubMed     Abstract available
    
    
    
60. NGUYEN DD, Ho NT, Dover LG, Vo AHM, et al
    Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.
    Emerg Infect Dis. 2024;30:1034-1036.
    PubMed     Abstract available
    
    
    April 2024
61. DOI A, Ota M, Saito M, Matsuyama S, et al
    Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available
    
    
    
62. MATTOCK J, Chattaway MA, Hartman H, Dallman TJ, et al
    A One Health Perspective on Salmonella enterica Serovar Infantis, an Emerging Human Multidrug-Resistant Pathogen.
    Emerg Infect Dis. 2024;30:701-710.
    PubMed     Abstract available
    
    
    
63. SPIVACK S, Gold JAW, Lockhart SR, Anand P, et al
    Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineae.
    Emerg Infect Dis. 2024;30:807-809.
    PubMed     Abstract available
    
    
    January 2024
64. MULCHANDANI R, Zhao C, Tiseo K, Pires J, et al
    Predictive Mapping of Antimicrobial Resistance for Escherichia coli, Salmonella, and Campylobacter in Food-Producing Animals, Europe, 2000-2021.
    Emerg Infect Dis. 2024;30:96-104.
    PubMed     Abstract available
    
    
    November 2023
65. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    PubMed     Abstract available
    
    
    
66. JACQUELINE C, Carrascoso GR, Gutierrez-Fernandez J, Rangel TV, et al
    Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021-2022.
    Emerg Infect Dis. 2023;29:2370-2373.
    PubMed     Abstract available
    
    
    
67. CIAPPONI A, Bardach A, Sandoval MM, Palermo MC, et al
    Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America.
    Emerg Infect Dis. 2023;29:2335-2344.
    PubMed     Abstract available
    
    
    
68. NIZAMUDDIN S, Khan EA, Chattaway MA, Godbole G, et al
    Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022.
    Emerg Infect Dis. 2023;29:2395-2397.
    PubMed     Abstract available
    
    
    
69. WU Y, Jiang T, He X, Shao J, et al
    Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant bla(OXA-232)-Carrying Klebsiella pneumoniae Sequence Type 15 Lineage.
    Emerg Infect Dis. 2023;29:2246-2256.
    PubMed     Abstract available
    
    
    October 2023
70. HAMILTON KA, Njoroge SM, Momanyi K, Murungi MK, et al
    Antimicrobial Resistance in Slaughterhouses, Kenya.
    Emerg Infect Dis. 2023;29:2155-2158.
    PubMed     Abstract available
    
    
    
71. LEE J, Sunny S, Nazarian E, Fornek M, et al
    Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016-2022.
    Emerg Infect Dis. 2023;29:1973-1978.
    PubMed     Abstract available
    
    
    January 2023
72. FU P, Zhou J, Yang C, Nijiati Y, et al
    Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.
    Emerg Infect Dis. 2023;30:29-38.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.